Buy vs. Lease Med Spa Equipment: A Cost Model

The lowest monthly payment can be the most expensive equipment decision.

A clinic owner comparing an aesthetic device purchase with a lease is not choosing between two prices. The decision changes cash timing, interest, service obligations, upgrade flexibility, residual value, tax treatment and the cost of getting out early.

The contract supplies the numbers. Utilization decides whether they work.

The short answer — United States, evidence checked July 26, 2026: Buying tends to preserve control and residual value but uses more cash and leaves the owner with obsolescence risk. Leasing can reduce the initial cash requirement and create a defined payment schedule, but return conditions, end-of-term charges and early termination can change the result. Compare complete contracts over the same period; do not compare a purchase price with a monthly lease payment.

This model is for an owner or operator deciding how to fund one identified device. It does not predict revenue, recommend a lender or device, or determine accounting, legal or tax treatment.

Start with the contract, not the label

“Buy,” “finance” and “lease” are commercial shorthand. The signed documents control the economics.

• Cash purchase: the buyer pays the acquisition cost up front and generally bears service, downtime and resale risk after any warranty.
• Financed purchase: the buyer uses a loan or equipment-finance agreement, adding interest, fees, liens and payment obligations to the ownership economics.
• Lease: the clinic pays for contractual use. The agreement may require return, offer a purchase option or create another end-of-term outcome.

A product described as a “$1 buyout lease,” “fair-market-value lease” or “equipment finance agreement” may allocate ownership, tax and end-of-term rights differently. The name is not enough. Review the payment schedule, security interest, purchase option, return rules, default provisions and who bears loss or damage.

Put every dollar on one timeline

The comparison fails when it places the full purchase price beside one lease payment. Choose one analysis horizon—often the planned holding period—and map both options across it.

For a financed purchase, record:

• down payment and closing fees;
• number and timing of payments;
• interest rate or factor and whether it can change;
• required insurance, service and software;
• balloon payment or other amount due;
• estimated sale proceeds at the end of the horizon; and
• costs to sell, transfer, deinstall or dispose of the device.

For a lease, record:

• advance payments, deposit and documentation fees;
• monthly payment and full term;
• service, software, consumables and insurance not included;
• annual escalators, taxes and late charges;
• purchase-option or renewal amount;
• return, shipping, deinstallation and condition requirements; and
• the early-termination formula—not a salesperson's summary of it.

ASSUMPTION: residual value, downtime, maintenance and future utilization are uncertain inputs. They should be stress-tested, not presented as facts.

Three numbers matter

1. Initial cash. This is the cash required before the first treatment: deposit or down payment, fees, delivery, installation, training, electrical or room work, insurance and opening supplies.

2. Total contractual cash. Add every payment and mandatory charge over the same holding period. Subtract only residual proceeds that the operator reasonably expects to receive and has labeled as an estimate.

3. Present cost. A dollar paid later is not identical to a dollar paid today. Discounting future payments at an operator-selected rate creates a present-value comparison. The selected discount rate is an assumption, not a market fact.

The calculator below reports all three. It does not include tax effects or forecast treatment demand.

Equipment cost comparison calculator

Enter terms from actual quotes. The prefilled zeros are placeholders, not market benchmarks. Results are ESTIMATES based entirely on operator inputs.

Shared assumptions

Analysis horizon (months)

Annual discount rate (%)

Financed purchase

Up-front cash: down payment, fees, installation ($)

Monthly finance payment ($)

Number of finance payments

Monthly service, software and insurance not above ($)

Balloon or end payment within horizon ($)

Estimated net resale proceeds at horizon ($)

Lease

Up-front cash: advance payments, fees, installation ($)

Monthly lease payment ($)

Number of lease payments

Monthly service, software and insurance not above ($)

Purchase option, return or end-of-term cost ($)

Compare entered terms

Utilization is the stress test

A cheaper contract can still be a bad decision if the device sits idle. The relevant operating input is contribution per completed treatment—not menu price.

ASSUMPTION: monthly device contribution equals completed paid treatments multiplied by the amount left after treatment-specific consumables, clinician compensation, card fees and other truly variable costs. Subtract the device's monthly payment, service, software and device-specific insurance to see whether the equipment contributes before shared clinic overhead.

Run at least three utilization cases:

• Downside: a slow ramp, cancellations and downtime.
• Base: a schedule supported by existing demand or a documented acquisition plan.
• Upside: higher use without assuming unlimited staff, room or patient capacity.

Do not let the upside case approve the contract. Ask whether the clinic can carry the payment under the downside case without compromising payroll, supplies or working capital.

Service terms can reverse the result

Device economics are not finished when financing is signed. Ask who pays for preventive maintenance, handpieces, calibration, software access, travel, parts and loaner equipment. Record warranty length, response commitments and exclusions.

A bundled service contract has value only to the extent its obligations are clear and useful. “Service included” does not answer response time, covered parts or what happens to payments while a device is unavailable.

For a used device, confirm whether the manufacturer will service it, whether software or consumable access transfers, and whether relocation or resale triggers fees. These are contract and vendor facts, not assumptions to fill with an industry average.

Verify the exact device

The FDA's Medical Device Databases page links records including 510(k) premarket notifications, Premarket Approvals, product classifications and establishment registration and listing.

Those databases can help match the manufacturer, device name, model or product code to a regulatory record. They do not provide prices, forecast demand, establish that a device is suitable for a clinic's intended use, or convert clearance, approval, registration and listing into interchangeable terms.

Before signing, match the quoted equipment and intended use to the exact FDA record and labeling. Route device-specific clinical and regulatory questions to qualified professionals.

Financing access is not an approval signal

The U.S. Small Business Administration states that its 7(a) program can support eligible uses including machinery and equipment, subject to lender and program requirements. Its separate 504 program provides long-term, fixed-rate financing for eligible major fixed assets through Certified Development Companies.

Program availability does not establish that borrowing for a particular device is prudent. Eligibility, underwriting, collateral, guarantees, fees, maturity and permitted use must be checked with the participating lender and current SBA materials.

The Federal Reserve Banks' Small Business Credit Survey is a national sample of firms with fewer than 500 employees focused on financing and debt needs and experiences. It is useful context for the credit environment. It is not med-spa-specific and does not supply terms for an individual borrower.

Tax treatment needs its own review

IRS Publication 946, How To Depreciate Property, explains depreciation, MACRS and the Section 179 deduction. It also addresses leased property and the incidents of ownership. That distinction matters because the contract label alone does not determine who may depreciate an asset.

The original assignment referenced IRS Publication 535, Business Expenses. The IRS now states in its Guide to Business Expense Resources that Publication 535 was discontinued after the 2022 revision and maps readers to current topic-specific resources.

FACT: the IRS materials describe federal tax rules. UNKNOWN: the treatment of a particular agreement until a qualified tax professional reviews the contract, taxpayer, placed-in-service date, business use and current law. A deduction affects after-tax cost; it does not make an uneconomic device free.

Use a sensitivity table

This table does not contain market forecasts. It shows which assumption to change and what the change can do to the comparison.

Swipe horizontally to compare every column.

Variable	Downside case	Base case	Upside case	Decision consequence
Completed paid treatments	Slow ramp and cancellations	Documented attainable schedule	Higher use within staff and room capacity	Tests whether fixed payments remain supportable
Downtime and service	Long outage; uncovered repair	Quoted service response	No material outage	Tests cash cost and revenue interruption without claiming either
Residual value	Zero after selling costs	Documented comparable estimate	Higher resale with supported buyer evidence	Often changes the ownership result most
Holding period	Exit before contract end	Complete planned term	Useful operation beyond finance term	Exposes termination, return and obsolescence risk
Consumable and software obligations	Minimums or increases apply	Quoted current obligations	Stable cost with no minimum	Changes contribution per treatment and total cash

A decision rule that survives the sales pitch

Buying or financing is more defensible when the clinic has durable utilization evidence, enough liquidity after the initial payment, tolerable service and obsolescence exposure, and a realistic plan to use or sell the asset beyond the comparison horizon.

Leasing is more defensible when preserving initial cash and creating a defined use period outweigh estimated residual value, and the return, renewal, purchase-option and early-exit terms are acceptable under a downside case.

Waiting is more defensible when demand is untested, the contract cannot be modeled from written terms, required service or software is unclear, or the downside case threatens core operating cash.

None of these is a universal verdict. A lower modeled cost does not cancel a bad termination clause, a device mismatch or unsupported demand.

The bottom line

Do not ask whether buying or leasing is always cheaper. Ask which complete contract produces the lower acceptable cost and risk for the clinic's planned holding period and documented utilization.

Get both proposals in writing. Enter every payment, service obligation, end-of-term charge and supportable residual estimate into the model. Run the downside case. Then send the same contracts—not a payment summary—to the clinic's attorney and tax professional before signing.